EVALUATION OF IOWA CANCER REGISTRY DATA LINKAGE WITH AMERICAN SOCIETY OF CLINICAL ONCOLOGY (ASCO) CANCERLINQ. POP 9/10/19 - 9/9/20.

监测，流行病学和最终结果（SEER）计划是最重要的癌症之一， 世界上的监测计划包括基于人群的癌症登记， 美国总人口的36%每年报告超过50万例癌症病例。爱荷华州 癌症登记处自1973年以来一直是SEER计划的成员。 ASCO CancerLinQ是一个旨在为肿瘤学家提供强大的质量监控系统的项目 收集和分析所有患者的数据，以提供最高的质量 对病人的照顾。CancerLinQ的最终目标是支持癌症的关键利益相关者， 社区包括患者、提供者、研究人员和政府。 爱荷华州癌症登记处和爱荷华州CancerLinQ实践之间的数据交换 服务区建立了一个数据管道， 电子健康记录。该试点项目旨在探索使用索赔作为一种形式， 用于癌症监测的详细结构化数据。理想情况下，索赔数据将提高 SEER登记，以获取癌症相关数据，并促进医疗保健提供者遵守 法律规定的公共卫生报告要求。索赔数据也可以支持 制定质量指标，可用作对供应商的反馈。

The Surveillance, Epidemiology, and End Results (SEER) Program is one of the premier cancer surveillance programs in the world comprised of population-based cancer registries covering 36% of the total US population reporting on over 500,000 cancer cases annually. The Iowa Cancer Registry has been a member of the SEER program since 1973. ASCO CancerLinQ is a program created to give oncologists a robust quality monitoring system that collects and analyzes data from all patient encounters to deliver the highest possible quality of care to patients. The ultimate goal of CancerLinQ is to support key stakeholders in the cancer community including patients, providers, researchers, and governments. A data exchange between the Iowa Cancer Registry and CancerLinQ practices in the Iowa catchment area established a data pipeline to capture discrete data elements recorded within electronic health records. This pilot was designed to explore the use of claims as a form of detailed, structured data for cancer surveillance. Ideally, claims data would enhance the ability of SEER registries to capture cancer related data and facilitate healthcare provider compliance with legally mandated public health reporting requirements. Claims data could also support development of quality metrics that could be used as feedback to the providers.